The Net Margin of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505.SS) is -22.89%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | -22.89% |
| 2024-12-31 | 5.64% |
| 2023-12-31 | 12.77% |
| 2022-12-31 | 13.38% |
| 2021-12-31 | 18.71% |
| 2020-12-31 | 19.75% |
| 2019-12-31 | 22.09% |
| 2018-12-31 | 15.11% |
| 2017-12-31 | 14.75% |